World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
13746
World Ranking
2625
National Ranking
1250

Berhane Ghebrehiwet publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Berhane Ghebrehiwet sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 273 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Berhane Ghebrehiwet D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Berhane Ghebrehiwet sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Berhane Ghebrehiwet is affiliated with Stony Brook University in the United States. Their research primarily focuses on fields related to Medicine and Immunology and Microbiology, with a substantial number of publications in these areas. Subfields of notable contribution include Immunology, Genetics, Molecular Biology, Infectious Diseases, and Hematology.

The scientist's research encompasses a range of topics with a particular concentration on the complement system in diseases, coagulation pathways including bradykinin and polyphosphates, and clinical studies of COVID-19. Key areas of work include monoclonal and polyclonal antibodies research, mast cells and histamine, blood groups and transfusion science, as well as investigations related to SARS-CoV-2 and COVID-19.

Frequent publication venues for Ghebrehiwet's work include:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Frontiers in Immunology
  • Frontiers in Oncology
  • The FASEB Journal
  • Frontiers in Allergy

Among recent significant papers are:

  • "SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems" (2021), published in Frontiers in Immunology
  • "Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis" (2021), published in Cellular and Molecular Gastroenterology and Hepatology
  • "Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology" (2020), published in Journal of Clinical Investigation
  • "gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma" (2020), published in Frontiers in Oncology
  • "GC1qR Cleavage by Caspase-1 Drives Aerobic Glycolysis in Tumor Cells" (2020), published in Frontiers in Oncology

Their frequent co-authors include Anne G. Savitt, Ellinor I.B. Peerschke, David A. Rubenstein, Wei Yin, and Allen P. Kaplan, reflecting collaborative work across multiple studies.

Best Publications

  • C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells

    Carol Anne Ogden;Aimee deCathelineau;Peter R. Hoffmann;Donna Bratton

  • Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.

    B Ghebrehiwet;B L Lim;E I Peerschke;A C Willis

  • gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes.

    Laurence Braun;Berhane Ghebrehiwet;Pascale Cossart

  • C1q Binds Phosphatidylserine and Likely Acts as a Multiligand-Bridging Molecule in Apoptotic Cell Recognition

    Helena Païdassi;Pascale Tacnet-Delorme;Virginie Garlatti;Claudine Darnault

  • Activation of the classical pathway of complement by Hageman factor fragment.

    B Ghebrehiwet;M Silverberg;A P Kaplan

  • Complement activation on platelets: implications for vascular inflammation and thrombosis.

    Ellinor I. Peerschke;Wei Yin;Berhane Ghebrehiwet

  • Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).

    Kusumam Joseph;Berhane Ghebrehiwet;Ellinor I. B. Peerschke;Kenneth B. M. Reid

  • Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets

    Truc Nguyen;Berhane Ghebrehiwet;Ellinor I. B. Peerschke

  • Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.

    Berhane Ghebrehiwet;Bruce P. Randazzo;Joseph T. Dunn;Michael Silverberg

  • Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin.

    Theodore Fields;Berhane Ghebrehiwet;Allen P. Kaplan

  • The plasma bradykinin-forming pathways and its interrelationships with complement

    Allen P. Kaplan;Berhane Ghebrehiwet

  • Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3.

    Yuqun Hong;Berhane Ghebrehiwet

  • gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection.

    Berhane Ghebrehiwet;Boon-Leong Lim;Rajeev Kumar;Xiaodong Feng

  • cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection

    Berhane Ghebrehiwet;Ellinor I.B Peerschke

  • Blood platelets activate the classical pathway of human complement

    E. I. B. Peerschke;W. Yin;S. E. Grigg;B. Ghebrehiwet

  • Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity.

    Ellinor I. B. Peerschke;Kenneth B. M. Reid;Berhane Ghebrehiwet

  • C1q as a unique player in angiogenesis with therapeutic implication in wound healing

    Fleur Bossi;Claudio Tripodo;Lucia Rizzi;Roberta Bulla

  • An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development

    Chiara Agostinis;Roberta Bulla;Claudio Tripodo;Angela Gismondi

  • Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations.

    Sarah Hom;Li Chen;Tony Wang;Berhane Ghebrehiwet

  • Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation.

    A. Chen;S. Gaddipati;Yuqun Hong;D. J. Volkman

  • The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor.

    Boon-Leong Lim;Kenneth B.M. Reid;Berhane Ghebrehiwet;Ellinor I.B. Peerschke

Frequent Co-Authors

Ellinor I.B. Peerschke
Ellinor I.B. Peerschke Memorial Sloan Kettering Cancer Center
Allen P. Kaplan
Allen P. Kaplan Medical University of South Carolina
Uday Kishore
Uday Kishore Brunel University London
Kenneth B. M. Reid
Kenneth B. M. Reid University of Oxford
Francesco Tedesco
Francesco Tedesco University of Trieste
Babette B. Weksler
Babette B. Weksler Cornell University
Paul Eggleton
Paul Eggleton University of Exeter
Tom Eirik Mollnes
Tom Eirik Mollnes Oslo University Hospital
Robert W. Colman
Robert W. Colman Temple University
Boon Leong Lim
Boon Leong Lim University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, pursuing related healthcare degrees can open diverse career opportunities. Many students consider advancing their credentials through accelerated nursing programs, which provide efficient pathways to enter vital clinical roles. For example, 12-month accelerated nursing programs online for non nurses offer a fast track for individuals aiming to transition into nursing without prior clinical experience.

Once in the nursing field, some professionals specialize further by earning certifications like acute care certification for fnp. This qualification allows Family Nurse Practitioners to expand their expertise to manage critically ill patients, enhancing their scope of practice and career flexibility.

For those interested in leadership or advanced clinical roles, enrolling in a nurse practitioner accelerated program online can be a strategic move. These programs compress extensive training into a shorter timeframe, helping candidates enter the workforce as qualified practitioners sooner.

Understanding financial prospects is also essential. The dnp salary varies by state, highlighting the importance of geographic considerations when planning a career. This information can help graduates make informed decisions about where to work for the best compensation and growth.

Best Scientists Citing Berhane Ghebrehiwet

Trending Scientists

Recently Published Articles